The overexpression of CSF2 has been associated with poor survival in patients with urothelial carcinoma and NF-κB-induced CSF2 has been shown to promote tumor metastasis in patients with lung cancer and breast cancer [31,32]. Here, CSF2 is linked to urothelial carcinoma.